Navigation Links
Prima BioMed Receives Regulatory Scientific Advice on CVac Phase III Trial
Date:2/18/2011

SYDNEY, Feb. 18, 2011 /PRNewswire/ -- Australian health care company Prima BioMed Ltd (ASX: PRR) (Prima) announced today that there has been an agreement for strategy and design of the Phase III clinical registration trial for the CVac™ immunotherapy therapeutic ovarian cancer vaccine.

The agreement comes after the European regulator, the European Medicines Agency (EMA) advised that Scientific Advice for the Phase III trial had successfully been granted.

Receiving Scientific Advice is a significant milestone in the timeline progression for CVac's global registration. Prima can now move forward and begin preparations for patient enrollment into international, registration directed trial.

The international CVac™ Phase III trial will provide statistically powered endpoints for progression free survival and also for overall survival.

Scientific Advice was granted after the EMA reviewed extensive data was analysed on the study design and endpoints. Evaluation of the ovarian cancer patient needs, the CVac™ dosing regimen, along with manufacturing and safety data from past clinical and preclinical data was compiled in order to allow the regulator to make a positive determination on the strategy and design of the upcoming clinical trial that will allow for registration.

The trial will be conducted on 750 patients in a double blind placebo controlled study randomized 1:1 of CVac vs. Standard of Care (currently there is no approved maintenance therapy for ovarian cancer), across multiple sites in Europe, the US and Australia. This will include the world renowned centres of Charite University Hospital in Berlin, Germany, under leadership of Prof Dr Jalid Sehouli, Bonn University, Germany under the leadership of Prof Dr Kuhn, Stanford Medical Centre in Palo Alto, California under world leading gynaelogical expert Dr Jonathan Berek, and Austin Hospital in Melbourne, Australia, under the leadership of Dr. Paul Mitchell The
'/>"/>

SOURCE Prima BioMed Ltd
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6

Related medicine technology :

1. Genzyme Announces Second Pivotal Mozobil Trial Meets Primary Endpoint
2. Lpath Demonstrates Strong Safety Profile of Lead Drug Candidate, Sphingomab(TM), in Non-Human Primates
3. New Research May Lead to Earlier Diagnosis and Treatment of Primary Biliary Cirrhosis in Families
4. ERBITUX(R) Meets Primary Endpoint of Increasing Survival in Phase III Lung Cancer Study
5. Anesiva Announces Pivotal Phase 3 Trial of Zingo(TM) Meets Primary Endpoint and Significantly Reduces Venous Access Pain in Adults
6. Tezampanel Meets Primary Endpoint in Phase IIb Clinical Trial in Acute Migraine Headache
7. ADVENTRX Meets Primary Endpoint in ANX-530 Marketing-Enabling Clinical Study
8. CSL Behring Reaches Primary Endpoint in Clinical Study of C1-INH for Treatment of Hereditary Angioedema
9. Clinical Studies of OvaRex in Advanced Ovarian Cancer Fail to Meet Primary Endpoint
10. Primary Endpoint of Pivotal Phase III Clinical Trial Achieved for Remoxy(TM)
11. Study of Pathwork Diagnostics Tissue of Origin Test Published in the Journal of Molecular Diagnostics: Investigates Test Reproducibility in Multiple Labs to Determine Primary Tumor in Cancer Cases
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/15/2014)... , Jan. 15, 2014 AARP Foundation today ... to support older adults suffering from the severe cold ... and its members are committed to helping those in ... and AARP Foundation will match dollar-for-dollar contributions up to ... The matching program will be administered through AARP Foundation. ...
(Date:1/15/2014)... 15, 2014 Shire plc (LSE: SHP, ... the Office of Fair Trading (OFT) approval condition to the ... ViroPharma Incorporated (NASDAQ: VPHM).   As a result ... OFT approval, and Shire expects to complete the tender offer ... subject to the satisfaction of all of the remaining conditions ...
(Date:1/15/2014)...  In an unprecedented effort to curb the spread of ... and other transport vehicles, an advanced and portable UV germicidal ... personnel for the first time. In order ... contact with these deadly pathogens, West Palm Beach ... to begin sanitizing the interior surfaces of its ambulance fleet ...
Breaking Medicine Technology:AARP Foundation Establishes Winter Relief Fund for Older Adults Suffering from the Severe Cold Weather 2AARP Foundation Establishes Winter Relief Fund for Older Adults Suffering from the Severe Cold Weather 3Shire Waives OFT Condition Relating to the Acquisition of ViroPharma Inc. 2Shire Waives OFT Condition Relating to the Acquisition of ViroPharma Inc. 3Superbugs No Longer Ride In Rescue Vehicles 2
(Date:4/14/2014)... treat children with uncomplicated acute appendicitis is a reasonable ... fewer missed school days, according to a pilot study. ... Hospital and published online April 12 in the ... the first prospective study on nonoperative management of acute ... , Researchers enrolled 77 patients age 7 to 17 ...
(Date:4/14/2014)... 2014, Perth, Australia. Drug discovery company Proteomics International ... of a companion diagnostic (CDx) test with the ... The research team authenticated the panel of biomarkers ... samples. Seven biomarkers were validated at high stringency ... The mass spectrometry data was then cross-validated using ...
(Date:4/14/2014)... 2014) When it comes to the cost and ... Patients get the best care when they are treated ... extensive experience in their current job, according to a ... and Columbia Business School. The study was published in ... Applied Economics . , The review of more ...
(Date:4/13/2014)... STANFORD, Calif. A low-cost empowerment program for ... and sexual harassment of these girls, who live ... and are frequently attacked, a large new study ... Stanford University School of Medicine, Lucile Packard Children,s ... No Worldwide, validated the program,s effectiveness in combating ...
(Date:4/11/2014)... the processes that control brain cell production could pave ... brain-related disorders. , Scientists have gained new understanding of ... how and when nerve and brain cells are formed ... and keeps it healthy. Their findings could help explain ... which is a fundamental characteristic of many diseases including ...
Breaking Medicine News(10 mins):Health News:Antibiotics alone are a successful treatment for uncomplicated acute appendicitis in kids 2Health News:Antibiotics alone are a successful treatment for uncomplicated acute appendicitis in kids 3Health News:Longer nurse tenure on hospital units leads to higher quality care 2Health News:Empowerment program greatly decreases incidence of rape, Stanford/Packard-led study finds 2Health News:Empowerment program greatly decreases incidence of rape, Stanford/Packard-led study finds 3Health News:Empowerment program greatly decreases incidence of rape, Stanford/Packard-led study finds 4
... , , , ... the Cure((R)), the world,s largest grassroots network of breast cancer survivors and ... Diego Affiliate will receive proceeds from the album release concert of Billboard-charting ... Supper Club, will feature Miz Mandy along with more than 20 band ...
... , SANTA CLARA, Calif., July 21 ... on the a lawsuit brought by Ormco Corporation (Ormco) against Align Technology, ... California (District Court), which was tried by jury June 9 through June ... previously disclosed, on June 26, 2009, the jury delivered a verdict against ...
... , ANDOVER, Mass., July 21 ... that serves the Texas Midwest area, finished its implementation of ... for advanced authentication. Following its enterprise roll-out of Sentillion,s ... Go to enable caregivers in its trauma center to use ...
... , SAVANNAH, Ga. July 21 Senator ... Chief Medical Officer of the Coastal Health District, Charles Powell, ... Coastal Area Agency on Aging, gathered today to urge all ... for diabetes. Together, they launched the Medicare Diabetes Screening ...
... strategies from the U.S. Surgeons General provided roadmap to take decisive ... , , AUSTIN, Texas and TUCSON, ... the Lance Armstrong Foundation (LAF), cancer survivor, and champion cyclist, battles ... National Call to Action on Cancer Prevention and Survivorship that ...
... putting their health at risk by avoiding disease screening, ... masculinity. Because they prove their masculinity through their sexuality ... goes against their notion of masculinity. Waverly Duck, a ... Yale University in the US, argues that current leading ...
Cached Medicine News:Health News:Susan G. Komen for the Cure(R), San Diego to Receive Proceeds from Miz Mandy Album Release Concert 2Health News:Susan G. Komen for the Cure(R), San Diego to Receive Proceeds from Miz Mandy Album Release Concert 3Health News:Align Technology Provides Update on Patent Litigation with Ormco Corporation 2Health News:Align Technology Provides Update on Patent Litigation with Ormco Corporation 3Health News:Align Technology Provides Update on Patent Litigation with Ormco Corporation 4Health News:Hendrick Health System Deploys Sentillion's Tap & Go Advanced Authentication Solution 2Health News:Hendrick Health System Deploys Sentillion's Tap & Go Advanced Authentication Solution 3Health News:Savannah City Leaders Launch Medicare Diabetes Screening Project 2Health News:Savannah City Leaders Launch Medicare Diabetes Screening Project 3Health News:First Anniversary of New War on Cancer Marks Many Advances 2Health News:First Anniversary of New War on Cancer Marks Many Advances 3Health News:First Anniversary of New War on Cancer Marks Many Advances 4Health News:First Anniversary of New War on Cancer Marks Many Advances 5Health News:First Anniversary of New War on Cancer Marks Many Advances 6Health News:First Anniversary of New War on Cancer Marks Many Advances 7Health News:'Go to the doctor? Only if I'm really sick...' 2
... TC-PLUS Solution tricompartmental total knee prosthesis stems ... arthroplasty. State-of-the-art design and manufacturing technologies have ... biomechanical function as well as a favorable ... insert to keep wear to a minimum. ...
... The TC-PLUS Solution tricompartmental total knee prosthesis ... knee arthroplasty. State-of-the-art design and manufacturing technologies ... optimum biomechanical function as well as a ... tibial insert to keep wear to a ...
... Knee System is a long term, quality ... Available in both posterior stabilized and anatomically ... System provides the flexibility needed to address ... ease of identification keeps the user in ...
... a long term, quality solution based on ... posterior stabilized and anatomically correct cruciate retaining ... flexibility needed to address patients' needs. In ... keeps the user in mind and promotes ...
Medicine Products: